Company / Operating Income
RIGEL PHARMACEUTICALS INC Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$125.5M
FY2025
5-year range
-$55.5M / $125.5M
FY2021-FY2025
Trend
+418.6%
vs FY2024
Sector context
#32 of 204
Health Care
What the data says
Operating Income changed +419% YoY in FY2025, a notable deviation from the 9-year average annual change of +52%.
Based on SEC 10-K filings.
$125M in FY2025. Top quartile in the Health Care sector.
Improved from -$20M to $125M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 204This company $125.5M Sector average $107.8M
▼
+16.4% above sector average
Key checks
Key Insights
- RIGEL PHARMACEUTICALS INC's operating income has grown for 3 consecutive years.
- In FY2025, operating income increased 418.6% year-over-year.
- Ranks #32 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $125.5M | +418.6% |
| FY2024 | $24.2M | +218.1% |
| FY2023 | -$20.5M | +63.1% |
| FY2022 | -$55.5M | -344.5% |
| FY2021 | -$12.5M | +56.9% |
| FY2020 | -$29.0M | +58.1% |
| FY2019 | -$69.1M | +0.9% |
| FY2018 | -$69.7M | +12.4% |
| FY2017 | -$79.6M | -14.2% |
| FY2016 | -$69.7M | -34.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026